Image

A Prospective Observational Study Using the FAM-CAM

A Prospective Observational Study Using the FAM-CAM

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

The goal of this observational study is to learn whether family members can help identify signs of delirium in adult patients who are staying in the intensive care unit. Delirium is a sudden change in attention, thinking, or awareness that can happen during serious illness.

The main question it aims to answer is:

Can family members notice possible signs of delirium that may not be found during routine ICU delirium screening? Participants will receive their usual medical care. Family members who know the patient well will complete a short delirium assessment called the FAM-CAM after visiting the patient. Nurses will continue to perform routine ICU delirium screening using the ICDSC as part of usual care. The study team will compare the family member's assessment with the nurse's routine assessment to see whether family observations provide additional helpful information.

Family members may complete the assessment for up to 3 days while the patient is in the ICU.

Eligibility

Inclusion Criteria

Patients
  • Aged 18 years or older.
  • Admitted to the ICU for at least 24 hours.
  • Richmond Agitation-Sedation Scale (RASS) score ≥ -3 at the time of enrollment.
  • Provided written informed consent to participate. When patients were unable to provide consent, consent was obtained from their legal surrogates.

Family Members:

  • Aged 18 years or older.
  • Identified as the patient's primary family caregiver.
  • Had visited the patient in the ICU at least once.
  • Were able to understand and communicate in Mandarin.
  • Provided written informed consent and voluntarily agreed to participate.

Exclusion Criteria

Patients
  • Persistent coma or deep sedation throughout the ICU stay, defined as Glasgow Coma Scale (GCS) score ≤ 8 or RASS score of -4 or -5.
  • A previously confirmed diagnosis of dementia, a severe psychiatric disorder, or an organic neurological disease.
  • Severe hearing impairment that prevented effective communication or study participation.

Family Members:

-Significant visual, hearing, or cognitive problems that prevented them from understanding the study procedures or completing the study assessments.

Study details
    Patients in ICU
    Delirium in the Intensive Care Unit
    Family

NCT07694687

Shanghai Zhongshan Hospital

15 August 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.